The relationship between testosterone-replacement therapy and lower urinary tract symptoms: A systematic review

Urology

Volumn 88, Issue , 2016, Pages 22-32

  Kathrins, Martin ^a   Doersch, Karen ^c   Nimeh, Tony ^b   Canto, Arturo ^d   Niederberger, Craig ^b   Seftel, Allen ^d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d Rowan University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE;

ANDROGEN THERAPY; COCHRANE LIBRARY; COHORT ANALYSIS; EMBASE; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; LOWER URINARY TRACT SYMPTOM; MALE; MEDLINE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATE VOLUME; REVIEW; SYSTEMATIC REVIEW; URODYNAMICS; CHEMICALLY INDUCED; CLINICAL TRIAL (TOPIC); HORMONE SUBSTITUTION; PROSPECTIVE STUDY;

CLINICAL TRIALS AS TOPIC; HORMONE REPLACEMENT THERAPY; HUMANS; LOWER URINARY TRACT SYMPTOMS; MALE; PROSPECTIVE STUDIES; TESTOSTERONE;

EID: 84960157428     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2015.11.006     Document Type: Article

References (64)

1. A.B. Araujo, G.R. Esche, V. Kupelian, and et al. Prevalence of symptomatic androgen deficiency in men J Clin Endocrinol Metab 92 2007 4241 4247
2. V. Kupelian, Wei J.T., M.P. O'Leary, and et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey Arch Intern Med 166 2014 2381 2387
3. J. Baillargeon, R.J. Urban, K.J. Ottenbacher, K.S. Pierson, and J.S. Goodwin Trends in androgen prescribing in the United States, 2001 to 2011 JAMA Intern Med 173 2014 2013 2014
4. V. Favilla, S. Cimino, T. Castelli, M. Madonia, I. Barbagallo, and G. Morgia Relationship between lower urinary tract symptoms and serum levels of sex hormones in men with symptomatic benign prostatic hyperplasia BJU Int 106 2010 1700 1703
5. H.J. Litman, S. Bhasin, M.P. O'Leary, C.L. Link, and J.B. McKinlay An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey BJU Int 100 2007 321 326
6. Wang C., E. Nieschlag, R. Swerdloff, and et al. Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations J Androl 30 2009 1 9
7. A.D. Seftel, M. Kathrins, and C. Niederberger Critical update of the 2010 endocrine society clinical practice guidelines for male hypogonadism: a systematic analysis Mayo Clin Proc 90 2015 1104 1115
8. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Int J Surg 8 2010 336 341
9. S.E. Canfield, and P. Dahm Rating the quality of evidence and the strength of recommendations using GRADE World J Urol 29 2011 311 317
10. R.M. Turpen, S.F. Fesperman, S. Sultan, and et al. Levels of evidence ratings in the urological literature: an assessment of interobserver agreement BJU Int 105 2010 602 606
11. L.S. Marks, N.A. Mazer, E. Mostaghel, and et al. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial JAMA 296 2006 2351 2361
12. M.H. Emmelot-vonk, H.J.J. Verhaar, and J.L.H.R. Bosch Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men JAMA 299 2008 39 52
13. S.Y. Kalinchenko, Y.A. Tishova, G.J. Mskhalaya, L.J.G. Gooren, E.J. Giltay, and F. Saad Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study Clin Endocrinol (Oxf) 73 2010 602 612
14. A. Haider, L.J.G. Gooren, P. Padungtod, and F. Saad A safety study of administration of parenteral testosterone undecanoate to elderly men over minimally 24 months Andrologia 42 2009 349 355
15. A. Haider, L.J. Gooren, P. Padungtod, and F. Saad Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men Andrologia 41 2009 7 13
16. B. Kühnert, M. Byrne, M. Simoni, and et al. Testosterone substitution with a new transdermal, hydroalcoholic gel applied to scrotal or non-scrotal skin: a multicentre trial Eur J Endocrinol 153 2005 317 326
17. H.M. Behre, S. von Eckardstein, S. Kliesch, and E. Nieschlag Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7-10 years Clin Endocrinol (Oxf) 50 1999 629 635
18. A.A. Yassin, and F. Saad Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only J Sex Med 4 2007 497 501
19. A.S. Dobs, A.W. Meikle, S. Arver, S.W. Sanders, K.E. Caramelli, and N.A. Mazer Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men J Clin Endocrinol Metab 84 1999 3469 3478
20. T. Minnemann, M. Schubert, D. Hübler, and et al. A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate Aging Male 10 2007 155 158
21. P.J. Snyder, H. Peachey, J.A. Berlin, and et al. Effects of testosterone replacement in hypogonadal men J Clin Endocrinol Metab 85 2000 2670 2677
22. S. Arver, A.S. Dobs, A.W. Meikle, and et al. Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men Clin Endocrinol (Oxf) 47 1997 727 737
23. D. Francomano, A. Ilacqua, R. Bruzziches, A. Lenzi, and A. Aversa Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome Urology 83 2014 167 173
24. S. Karazindiyanoʇlu, and S. Cayan The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism Aging Male 11 2008 146 149
25. K. Shigehara, K. Sugimoto, H. Konaka, and et al. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study Aging Male 14 2011 53 58
26. Wang C., G. Cunningham, A. Dobs, and et al. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men J Clin Endocrinol Metab 89 2004 2085 2098
27. J.-J. Legros, E.J.H. Meuleman, J.M.H. Elbers, T.B.P. Geurts, M.J.G.H. Kaspers, and P.M.G. Bouloux Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study Eur J Endocrinol 160 2009 821 831
28. G.A. Wittert, I.M. Chapman, M.T. Haren, S. Mackintosh, P. Coates, and J.E. Morley Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status J Gerontol A Biol Sci Med Sci 58 2003 M618 M625
29. U. Srinivas-Shankar, S.A. Roberts, M.J. Connolly, and et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study J Clin Endocrinol Metab 95 2010 639 650
30. H.S. Chiang, T.I.S. Hwang, Y.S. Hsui, and et al. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function Int J Impot Res 19 2007 411 417
31. A.M. Kenny, A. Kleppinger, K. Annis, and et al. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty J Gerontol A Biol Sci Med Sci 56 2010 1134 1143
32. A.M. Kenny, G. Fabregas, Song C., B. Biskup, and S. Bellantonio Effects of testosterone on behavior, depression, and cognitive function in older men with mild cognitive loss J Gerontol A Biol Sci Med Sci 59 2004 75 78
33. Tan W.S., W.Y. Low, C.J. Ng, and et al. Efficacy and safety of long-acting intramuscular testosterone undecanoate in aging men: a randomised controlled study BJU Int 111 2013 1130 1140
34. J.M. Kaufman, M.G. Miller, J.L. Garwin, S. Fitzpatrick, C. McWhirter, and J.J. Brennan Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men J Sex Med 8 2011 2079 2089
35. C. Steidle, S. Schwartz, K. Jacoby, T. Sebree, T. Smith, and R. Bachand AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function J Clin Endocrinol Metab 88 2003 2673 2681
36. A. Pechersky V, V.I. Mazurov, V.F. Semiglazov, A.I. Karpischenko, V. Mikhailichenko V, and A.V. Udintsev Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume Int J Androl 25 2002 119 125
37. J.C. Kaminetsky, B. Moclair, M. Hemani, and M. Sand A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treatment of male hypogonadism J Sex Med 8 2011 1186 1196
38. T.A. McNicholas, J.D. Dean, H. Mulder, C. Carnegie, and N.A. Jones A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function BJU Int 91 2003 69 74
39. C. Fennell, G. Sartorius, L.P. Ly, and et al. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men Clin Endocrinol (Oxf) 73 2010 102 109
40. J. Rodriguez-Tolrà, J. Torremadé, S. di Gregorio, L. Del Rio, and E. Franco Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome Andrology 1 2013 570 575
41. T. Amano, T. Imao, K. Takemae, T. Iwamoto, and M. Nakanome Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients Aging Male 13 2010 242 246
42. A. Kenny, K. Prestood, and L. Raisz Short-term effects of intramuscular and transdermal testosterone on bone turnover, prostate symptoms, cholesterol, and hematocrit in men over 70 with low testosterone levels Endocr Res 26 2000 153 168
43. S. Kalinchenko, E.L. Vishnevskiy, A.N. Koval, G.J. Mskhalaya, and F. Saad Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study Aging Male 11 2008 57 61
44. F. Saad, L. Gooren, A. Haider, and A. Yassin An exploratory study of the effects of 12 month administration of the novel long-acting testosterone undecanoate on measures of sexual function and the metabolic syndrome Syst Biol Reprod Med 53 2007 353 357
45. D.-J. Yassin, G. Doros, P.G. Hammerer, and A.A. Yassin Long-term testosterone treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome and health-related quality of life J Sex Med 11 2014 1567 1576
46. J.P.T. Higgins, D.G. Altman, P.C. Gotzsche, and et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials BMJ 343 2 2011 d5928
47. A.J. Wein Classification of neurogenic voiding dysfunction J Urol 125 1981 605 609
48. H.M. Behre, J. Bohmeyer, and E. Nieschlag Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls Clin Endocrinol (Oxf) 40 1994 341 349
49. Jin B., A.J. Conway, and D.J. Handelsman Effects of androgen deficiency and replacement on prostate zonal volumes Clin Endocrinol (Oxf) 54 2001 437 445
50. A.M. Isidori, J. Buvat, G. Corona, and et al. A critical analysis of the role of testosterone in erectile function: from pathophysiology to treatment - a systematic review Eur Urol 65 2014 99 112
51. S. Bhasin, G.R. Cunningham, F.J. Hayes, and et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 95 2010 2536 2559
52. O.M. Calof, A.B. Singh, M.L. Lee, and et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials J Gerontol 60 2005 1451 1457
53. Board of Directors. AUA position statement on testosterone therapy: American Urological Association. Available at: https://www.auanet.org/education/testosterone-therapy.cfm. Accessed December 21, 2016.
54. J.A. Pearl, D. Berhanu, N. François, and et al. Testosterone supplementation does not worsen lower urinary tract symptoms J Urol 190 2013 1828 1833
55. G.S. Prins, and K.S. Korach The role of estrogens and estrogen receptors in normal prostate growth and disease Steroids 73 2009 233 244
56. S.T. Page, Lin D.W., E.A. Mostaghel, and et al. Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial J Clin Endocrinol Metab 96 2011 430 437
57. E.A. Jannini, G.L. Gravina, A. Mortengaler, A. Morales, L. Incrocci, and W.J.G. Hellstrom Is testosterone a friend or a foe of the prostate? J Sex Med 8 2011 946 955
58. M. Zitzmann, M. Depenbusch, J. Gromoll, and E. Nieschlag Prostate volume and growth in testosterone-substituted hypogonadal men are dependent on the CAG repeat polymorphism of the androgen receptor gene: a longitudinal pharmacogenetic study J Clin Endocrinol Metab 88 2003 2049 2054
59. L. Vignozzi, G. Rastrelli, G. Corona, M. Gacci, G. Forti, and M. Maggi Benign prostatic hyperplasia: a new metabolic disease? J Endocrinol Invest 37 2014 313 322
60. C. De Nunzio, L. Cindolo, M. Gacci, and et al. Metabolic syndrome and lower urinary tract symptoms in patients with benign prostatic enlargement: a possible link to storage symptoms Urology 84 2014 1181 1187
61. A.K. Chavalmane, P. Comeglio, A. Morelli, and et al. Sex steroid receptors in male human bladder: expression and biological function J Sex Med 7 2010 2698 2713
62. S. Celayir Effects of different sex hormones on male rabbit urodynamics: an experimental study Horm Res 60 2003 215 220
63. L.M.D. Shortliffe, Ye Y., B. Behr, and Wang B. Testosterone changes bladder and kidney structure in juvenile male rats J Urol 191 2014 1913 1919
64. T.M. Nicholson, M.A. Moses, K.S. Uchtmann, and et al. Estrogen receptor-α is a key mediator and therapeutic target for bladder complications of benign prostatic hyperplasia J Urol 193 2014 722 729